UNITED THERAPEUTICS (UTH MU) stock market data APIs
€431.2815
0(0%)
as of September 24, 2026
Try our APIs with
free plan!
UNITED THERAPEUTICS Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for UTH.MU.
Prev. Close
431.2815
Open
431.2815
High
431.2815
Low
431.2815
52 wk Range
357-514
Market Cap
7 520 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get UNITED THERAPEUTICS data using free add-ons & libraries
Get UNITED THERAPEUTICS Fundamental Data
UNITED THERAPEUTICS Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
UNITED THERAPEUTICS News
New
Can LQDA's Yutrepia Outpace Intensifying PAH Competition?
Liquidia Corporation LQDA is gaining strong commercial momentum with Yutrepia, but intensifying competition in the pulmonary arterial hypertension (PAH) market could make it increasingly challenging f...
Biotech Options Buzz: UTHR, NMRA, EWTX
Biotech stocks are dominating today's unusual options volume list, with United Therapeutics Corporation (NASDAQ: UTHR), Neumora Therapeutics Inc (NASDAQ: NMRA), and Edgewise Therapeutics Inc (NASDAQ: ...
1 Cash-Heavy Stock to Target This Week and 2 We Question
1 Cash-Heavy Stock to Target This Week and 2 We Question A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limi...
LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now?
Shares of Liquidia Corporation LQDA have lost 13.9% in a month against the industry's growth of 1.5%. The stock has lagged the broader sector and the S&P 500 Index. The selloff accelerated after Liqu...
Get UNITED THERAPEUTICS fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
